Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Thomas Ross

Family Medicine Des Moines, IA Doctor of Osteopathy

NPI 1114997731 CMS profile 5199

1000 E. Army Post Rd, Des Moines, IA 50315

Open in the dashboard

General payments

$169,928

203 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thomas Ross of Des Moines, IA is reported in the CMS Open Payments database as having received $169,928 across 203 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Family Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $14,102 14
2024 General $16,954 18
2023 General $23,932 26
2022 General $60,798 62
2021 General $35,798 39
2020 General $1,375 1
2019 General $16,969 43

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Ross
  • Family Medicine median
  • Middle half of Family Medicine
  • National median

In program year 2025, general payments to Thomas Ross were reported at $14,102. Among 56,786 Family Medicine profiles paid that year, the median was $155 and the middle half received between $45 and $549.

Show as a table
Year Thomas Ross Family Medicine median Middle half National median
2019 $16,969 $150 $41–$543 $163
2020 $1,375 $120 $32–$415 $114
2021 $35,798 $137 $35–$551 $132
2022 $60,798 $137 $37–$512 $149
2023 $23,932 $149 $42–$545 $160
2024 $16,954 $156 $44–$560 $164
2025 $14,102 $155 $45–$549 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Organon LLC $139,394 145 payments
  2. Merck Sharp & Dohme Corporation $30,495 57 payments
  3. AstraZeneca Pharmaceuticals LP $39 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for serving as faculty or as a speaker for a medical education program $115,786 120 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $49,925 37 payments
  3. Travel and Lodging $3,873 30 payments
  4. Food and Beverage $345 16 payments
Products named General payments · program years 2019–2025
  1. NEXPLANON Etonogestrel $115,786 120 payments
  2. NEXPLANON Womens Health $30,495 57 payments
  3. Nexplanon Womens Health $23,593 24 payments
  4. FARXIGA $39 1 payment
  5. NEXPLANON Contraceptives $15 1 payment

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

203 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Family Medicine in Iowa

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record